PROCEPT BioRobotics Corporation stock rating and score history
All changes in ratings, performance and outlook tracked over time.
PROCEPT BioRobotics Corporation stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does PROCEPT BioRobotics Corporation do? Business model and key facts
Get the full picture of PROCEPT BioRobotics Corporation: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 756
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Stocks related to PROCEPT BioRobotics Corporation
Selected based on industry alignment and relative market positioning.
Events and news impacting PROCEPT BioRobotics Corporation stock
Earnings, coporate decisions and industry developments that can affect the share price.
PROCEPT BioRobotics Corporation fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
